CIS Presents at Medicaid Event, Launches New Industry Blog
CIS announced today that three of its Government Programs experts will be speaking at CBI’s 12th Annual Medicaid Rebates Conference being held May 12 – 14 at Lake Buena Vista, Florida, USA. In addition to its speaking engagement at and sponsorship of the CBI Medicaid event, CIS will launch its improved Pharma Compliance Blog from its booth on the exhibit floor.
Philadelphia, PA, May 09, 2010 --(PR.com)-- Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm, announced today that three of its Government Programs experts will be speaking at CBI’s 12th Annual Medicaid Rebates Conference being held May 12 – 14 at Lake Buena Vista, Florida, USA.
Chris Cobourn, CIS Vice President of Regulatory Compliance, will present, “Product Divestitures and Company Mergers & Acquisitions – Due Diligence on the Financial and Compliance Impact on Government Programs,” on Thursday, May 13.
CIS Director of Government Programs Consulting Services Amy VanDeCar will moderate the panel discussion, “Considerations for Auditing and Monitoring within the Medicaid Drug Rebate Program” on Friday, May 14. Joining VanDeCar on the panel discussion will be executives from Daiichi Sanyo, Sanofi-Aventis, Procter & Gamble, and Nycomed US.
In addition, Lisa McNair, CIS Senior Manager of TRICARE Contracting, will participate in the workshop, “Best Practices for Pricing and Contracting with FSS, VA, DoD and PHS Programs” on Friday, May 14.
In addition to its sponsorship of the CBI Medicaid event, CIS will launch its improved Pharma Compliance Blog from its booth on the exhibit floor. The new blog (www.pharmacomplianceblog.com) provides its readers with new search functionality and a more intuitive user interface. Started in 2007, the Pharma Compliance Blog is the only blog that captures content dealing with the entire pharmaceutical lifecycle (i.e., clinical, manufacturing, commercial compliance and Government Programs).
About CIS
Compliance Implementation Services (CIS) is a consulting firm specializing in compliance strategies for pharmaceutical companies, from Global Clinical Research and Development through U.S. Commercial Compliance and Government Programs. Founded in 2004, the firm’s deep understanding of industry laws and regulations, innovative and practical applications, and custom solutions help its clients establish a “Culture of Compliance” that is both meaningful and practical.
CIS experts quickly identify exposure to compliance risks, help develop a strategic plan, and ensure its implementation and ongoing adherence to legal and regulatory requirements. For more information, visit www.cis-partners.com.
###
Chris Cobourn, CIS Vice President of Regulatory Compliance, will present, “Product Divestitures and Company Mergers & Acquisitions – Due Diligence on the Financial and Compliance Impact on Government Programs,” on Thursday, May 13.
CIS Director of Government Programs Consulting Services Amy VanDeCar will moderate the panel discussion, “Considerations for Auditing and Monitoring within the Medicaid Drug Rebate Program” on Friday, May 14. Joining VanDeCar on the panel discussion will be executives from Daiichi Sanyo, Sanofi-Aventis, Procter & Gamble, and Nycomed US.
In addition, Lisa McNair, CIS Senior Manager of TRICARE Contracting, will participate in the workshop, “Best Practices for Pricing and Contracting with FSS, VA, DoD and PHS Programs” on Friday, May 14.
In addition to its sponsorship of the CBI Medicaid event, CIS will launch its improved Pharma Compliance Blog from its booth on the exhibit floor. The new blog (www.pharmacomplianceblog.com) provides its readers with new search functionality and a more intuitive user interface. Started in 2007, the Pharma Compliance Blog is the only blog that captures content dealing with the entire pharmaceutical lifecycle (i.e., clinical, manufacturing, commercial compliance and Government Programs).
About CIS
Compliance Implementation Services (CIS) is a consulting firm specializing in compliance strategies for pharmaceutical companies, from Global Clinical Research and Development through U.S. Commercial Compliance and Government Programs. Founded in 2004, the firm’s deep understanding of industry laws and regulations, innovative and practical applications, and custom solutions help its clients establish a “Culture of Compliance” that is both meaningful and practical.
CIS experts quickly identify exposure to compliance risks, help develop a strategic plan, and ensure its implementation and ongoing adherence to legal and regulatory requirements. For more information, visit www.cis-partners.com.
###
Contact
Compliance Implementation Services
Marni Schribman
484-445-7255
www.cis-partners.com
Marni Schribman
484-445-7255
www.cis-partners.com
Contact
Categories